Try the modernized beta website. Learn more about the modernization effort.

Key Record Dates Identifier: NCT04190056
Brief Title: Pembrolizumab and Tamoxifen With or Without Vorinostat for the Treatment of Estrogen Receptor Positive Breast Cancer

First Submitted : December 4, 2019
First Submitted that Met QC Criteria : December 4, 2019
First Posted : December 9, 2019

Last Update Submitted that Met QC Criteria : July 1, 2021
Last Update Posted : July 6, 2021